Formulation Guides

Enteric-Coated Pellets: Sample Qualification

Prepare an enteric-coated pellets enquiry and qualify gastro-resistance, the medium transition and later release for the intended dosage form.

White pharmaceutical pellets on a stainless steel inspection surface

When sourcing enteric-coated pellets, define the acid-stage and subsequent release objectives before asking a manufacturer for data. The two stages answer separate questions. Record the intended capsule or tablet process so the technical team can decide where gastro-resistance needs to be reassessed.

Establish which material the results describe

Ask for the material name, exact active form, loading basis, batch and sample preparation. Use the same identifiers in the product specification, data report and enquiry. For a comparison involving Esomeprazole EC Pellets or Omeprazole EC (WW), first confirm that the data refer to the proposed catalogue item and chemical form.

Document the transition between stages

Enteric qualification evidence by stage
StageRecordQuestion to resolve
Before the runApparatus, amount tested, active reporting basis and method revisionDo both parties mean the same material and test procedure?
Acid stageMedium, duration, sampling point and gastro-resistance criterionWhat happens under the specified acidic conditions?
TransitionHow the medium changes and when the next stage startsIs the later sampling clock comparable between data sets?
Later stageMedium, time points, acceptance criteria and batch resultsDoes the material perform as intended under the later conditions?

If one report describes the pellets as supplied and another describes a finished capsule or tablet, retain that distinction in the trial record. Transfer, blending, filling or compaction can change the evaluation required. Define the finished-product tests with the responsible formulation and QA teams. EMA guidance for finished oral modified-release products

Identify when the design needs a separate evaluation

For Dexlansoprazole DDR, ask how the proposed dual delayed-release stages are achieved and measured. Review the release profile comparison before choosing the evidence package. The enteric catalogue section shows the relevant Rraynex references.

Frequently Asked Questions

Is an acid-stage result enough for supplier qualification?

Review the acid-stage result, later release data and test method together. Confirm that both stages correspond to the proposed material and intended dosage form.

Can I use a universal acid-stage limit for all EC pellets?

Agree acceptance criteria for the specific material and intended formulation. Record the applicable method and basis with the limit.

Put insight into practice

Let’s discuss your
next formulation project.

Share your product, strength, release requirements, expected quantity and destination market with our team.

Discuss enteric-coated pellet specifications

Share this article

LinkedInXWhatsApp

Back to all insights
View all insights
Pharmaceutical granules entering a stainless steel collection tray

Formulation Guides

2 min read

DC Granules: Press Trial Guide

Compare directly compressible granules using a practical press trial brief for feeding, tablet weight, mechanical strength and finished-tablet tests.

Read article